Divis Laboratories posted stable quarterly results for Q4FY18 with steady revenue growth and marginal bottom-line increase.

Avanti Feeds reported subdued results for the quarter. The revenue saw strong gain over the previous year, however the operating profits and bottom-line were weak for the quarter

The PAT for the quarter came in at Rs. 10.27 crore, yoy increase of 174.6 per cent. This was due to jump in other income to Rs. 3.64 crore in Q4FY18 vs Rs. 1.50 crore in Q4FY17.

Looking at the full year numbers, we see that revenue jumped by 5 per cent to reach Rs. 1,557.16 crore while EBITDA rose by 21 per cent to Rs. 200.03 crore.

Overall volumes in futures & options currently stand at 83.59 crore contracts with a turnover of Rs. 7,04,102.93 crore.

Overall volumes in futures & options currently stand at 83.59 crore contracts with a turnover of Rs. 7,04,102.93 crore.

Going ahead, we expect Nifty to advance to the level of 10,665-10,674 and it may face resistance around this level as it is a confluence of 21-day SMA and 50 per cent retracement level of the recent downmove. Stocks in news: Welspun Enterprises, ITDC, Torrent Pharma, UBL, Dr Reddy’s Laboratories, Himatsingka Seide, Dilip Buildcon, MEP Infrastructure Developers, IDBI Bank, Punj Lloyd and Cadila Healthcare.

Indian markets are likely to make mildly positive start as Asian peers are lacking clear direction. The trading of Nifty 50 index futures on the Singapore stock exchange indicates that the Nifty may open with modest gains of 8 points around the level of 10,647.  

If you have been planning for retirement, you need to make sure that the retirement corpus will be adequate enough to meet your post-retirement needs. More importantly, your retirement corpus has to be safe and secure and should not be exposed to the risk of capital erosion.